24.65
0.00 (-0.02%)
| Penutupan Terdahulu | 24.65 |
| Buka | 24.63 |
| Jumlah Dagangan | 1,068,309 |
| Purata Dagangan (3B) | 1,183,640 |
| Modal Pasaran | 1,150,284,928 |
| Harga / Jualan (P/S) | 1.63 |
| Harga / Buku (P/B) | 1.48 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 May 2026 |
| Margin Keuntungan | -55.80% |
| Margin Operasi (TTM) | 6.15% |
| EPS Cair (TTM) | -8.27 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.79% |
| Nisbah Semasa (MRQ) | 2.57 |
| Aliran Tunai Operasi (OCF TTM) | 134.40 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 131.31 M |
| Pulangan Atas Aset (ROA TTM) | 2.26% |
| Pulangan Atas Ekuiti (ROE TTM) | -36.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Avanos Medical, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | -0.63 |
|
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.80% |
| % Dimiliki oleh Institusi | 96.13% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Clark Estates Inc/Ny | 31 Dec 2025 | 888,880 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DELGADO SIGFRIDO | - | 24.65 | -4,264 | -105,108 |
| GALOVAN SCOTT MICHAEL | - | 24.65 | -4,228 | -104,220 |
| Jumlah Keseluruhan Kuantiti Bersih | -8,492 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -209,328 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 24.65 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| DELGADO SIGFRIDO | Pegawai | 22 Apr 2026 | Dibuang (-) | 4,264 | 24.65 | 105,108 |
| GALOVAN SCOTT MICHAEL | Pegawai | 22 Apr 2026 | Dibuang (-) | 4,228 | 24.65 | 104,220 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Feb 2026 | Pengumuman | CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |